Cargando…

Improved prediction of cardiovascular events in diabetic patients: Role of quantitative ultrasonic tissue characterization

Detalles Bibliográficos
Autores principales:	Sheen, Yi‐Jing, Sheu, Wayne H‐H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley-Blackwell 2014
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025234/ https://www.ncbi.nlm.nih.gov/pubmed/24843731 http://dx.doi.org/10.1111/jdi.12109

Ejemplares similares

Ultrasonic Tissue Characterization of Carotid Plaque Improves the Prediction of Cardiovascular Events in Diabetic Patients: A pilot study
por: Katakami, Naoto, et al.
Publicado: (2012)

History of gestational diabetes and future cardiovascular disease: What have we learned?
por: Hsu, Cherng‐Lan, et al.
Publicado: (2018)

Markers of Apoptosis Predict Cardiovascular Outcomes and Point to ‘Response to Injury’ as a Common Pathway Leading to Diabetes and Cardiovascular Events
por: Hartley, Adam, et al.
Publicado: (2018)

Alteration of insulin sensitivity by sex hormones during the menstrual cycle
por: Sheu, Wayne H‐H
Publicado: (2011)

Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors
por: Sheu, Wayne H‐H
Publicado: (2020)

Hypoglycemia, Diabetes, and Cardiovascular Events
por: Desouza, Cyrus V., et al.
Publicado: (2010)

From sugar to kidney: A never‐ending battle
por: Lin, Yu‐Feng, et al.
Publicado: (2014)

Impact of Liver Cirrhosis on Incidence of Dialysis Among Patients with Type 2 Diabetes
por: Sheen, Yi-Jing, et al.
Publicado: (2020)

Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
por: Giugliano, Dario, et al.
Publicado: (2020)

Commentary on risk factors for first and subsequent cardiovascular disease events in type 1 diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study
por: Lin, Chun‐Hsien, et al.
Publicado: (2020)

Metabolic Syndrome and Renal Injury
por: Sheen, Yi-Jing, et al.
Publicado: (2011)

The importance of improving health literacy to lower cardiovascular risk in type 2 diabetes
por: Hansen, Dominique, et al.
Publicado: (2019)

Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes: Meta-analysis of observational studies
por: Kramer, Caroline K., et al.
Publicado: (2011)

Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
por: de Boer, Ian H., et al.
Publicado: (2018)

Serum Renalase Levels Are Predicted by Brain-Derived Neurotrophic Factor and Associated with Cardiovascular Events and Mortality after Percutaneous Coronary Intervention
por: Lee, I-Te, et al.
Publicado: (2018)

Quantitative characterization of myocardial infarction by cardiovascular magnetic resonance predicts future cardiovascular events in patients with ischemic cardiomyopathy
por: Yokota, Hajime, et al.
Publicado: (2008)

Controversy about the relationship between sulfonylurea use and cardiovascular events and mortality
por: Shimoda, Masashi, et al.
Publicado: (2016)

Impact of chronic hepatitis on cardiovascular events among type 2 diabetes patients in Taiwan pay-for-performance program
por: Sheen, Yi-Jing, et al.
Publicado: (2022)

Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus
por: van der Leeuw, Joep, et al.
Publicado: (2016)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Myocardial ultrasonic tissue characterization in patients with thyroid dysfunction
por: Romano, Minna MD, et al.
Publicado: (2010)

Quantitative characterization of the urine and serum metabolomes of children is essential for ‘omics’ studies
por: DiBattista, Alicia, et al.
Publicado: (2018)

Association between thermal threshold abnormalities and peripheral artery disease in patients with type 2 diabetes
por: Sheen, Yi-Jing, et al.
Publicado: (2018)

Peripheral Arterial Stiffness Is Independently Associated with a Rapid Decline in Estimated Glomerular Filtration Rate in Patients with Type 2 Diabetes
por: Sheen, Yi-Jing, et al.
Publicado: (2013)

ON NO—The Continuing Story of Nitric Oxide, Diabetes, and Cardiovascular Disease
por: Bøtker, Hans Erik, et al.
Publicado: (2013)

Artificially intelligent proteomics improves cardiovascular risk assessment
por: Sze, Siu Kwan
Publicado: (2019)

Perindopril for improving cardiovascular events
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Improving the Linkages between Air Pollution Epidemiology and Quantitative Risk Assessment
por: Fann, Neal, et al.
Publicado: (2011)

Can Circulating Regulatory T Cells Predict Cardiovascular Disease?
por: Björkbacka, Harry
Publicado: (2016)

PDM-ProValue meets cardiovascular outcome trials in diabetes
por: Fritzen, Katharina, et al.
Publicado: (2019)

Improving Prediction of Risk for the Development of Type 1 Diabetes—Insights From Populations at High Risk
por: Wherrett, Diane K.
Publicado: (2021)

A Generalized Gamma Mixture Model for Ultrasonic Tissue Characterization
por: Vegas-Sanchez-Ferrero, Gonzalo, et al.
Publicado: (2012)

Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes trial: A post‐hoc analysis
por: Aso, Yoshimasa
Publicado: (2021)

Heart and Brain Tissue Banks for Research on Co-Occurring Cardiovascular and Neurological/Psychiatric Disorders
por: Ikonomovic, Milos D.
Publicado: (2009)

Training and Retaining Physician‒Scientists in Dermatology in Taiwan
por: Sheen, Yi-Shuan, et al.
Publicado: (2021)

Filamin A mediated Big2 dependent endocytosis: From apical abscission to periventricular heterotopia
por: Sheen, Volney L
Publicado: (2014)

Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes
por: Regan, Jessica A., et al.
Publicado: (2023)

Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?
por: Schernthaner, Guntram, et al.
Publicado: (2018)

Marijuana Use Impacts Midlife Cardiovascular Events in HIV-Infected Men
por: Lorenz, David R., et al.
Publicado: (2017)

Clinical Trial Technologies for Improving Equity and Inclusion in Cardiovascular Clinical Research
por: Broadwin, Cassandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_49alt2mh14jo5icrh2ov5tja7m